Availability of Non-Exclusive, Exclusive License or Partially Exclusive Licensing of U.S. Patent Concerning Polymerization of Aromatic Monomers Using Derivatives of Hematin, 67921 [E7-23368]

Download as PDF Federal Register / Vol. 72, No. 231 / Monday, December 3, 2007 / Notices documents from the General Services Administration, Regulatory Secretariat (VIR), 1800 F Street, NW, Room 4035, Washington, DC 20405, telephone (202) 501–4755. Please cite OMB Control No. 9000–0155, Prohibition on Acquisition of Products Produced by Forced or Indentured Child Labor, in all correspondence. Dated: November 21, 2007. Al Matera, Director, Office of Acquisition Policy. [FR Doc. 07–5918 Filed 11–30–07; 8:45 am] BILLING CODE 6820–EP–S Missile Defense Agency, in consultation with the Missile Defense Agency Office of General Counsel, has determined in writing that the public interest requires that all sessions of the committee’s meeting will be closed to the public because they will be concerned with classified information and matters covered by section 5 U.S.C. 552b(c)(1). Committee’s Designated Federal Officer: Mr. Al Bready, mdac@mda.mil, phone/voice mail 703–695–6438, or mail at 7100 Defense Pentagon, Washington, DC 20301–7100. Pursuant to 41 CFR 102–3.105(j) and 102–3.140, and section 10(a)(3) of the Federal Advisory Committee Act of 1972, the public or interested organizations may submit written statements to the membership of the Missile Defense Advisory Committee about its mission and functions. Written statements may be submitted at any time or in response to the stated agenda of a planned meeting of the Missile Defense Advisory Committee. All written statements shall be submitted to the Designated Federal Officer for the Missile Defense Advisory Committee, in the following formats: one hard copy with original signature and one electronic copy via e-mail (acceptable file formats: Adobe Acrobat PDF, MS Word or MS PowerPoint), and this individual will ensure that the written statements are provided to the membership for their consideration. Contact information for the Designated Federal Officer is as stated above and can also be obtained from the GSA’s Federal Advisory Committee Act Database—https://www.fido.gov/ facadatabase/public.asp. Statements being submitted in response to the agenda mentioned in this notice must be received by the Designated Federal Officer at the address listed at least five calendar days prior to the meeting which is the subject of this notice. Written statements received after this date may not be provided to or considered by the Missile Defense Advisory Committee until its next meeting. The Designated Federal Officer will review all timely submissions with the Missile Defense Advisory Committee Chairperson and ensure they are provided to all members of the Missile Defense Advisory Committee before the meeting that is the subject of this notice. SUPPLEMENTARY INFORMATION: DEPARTMENT OF DEFENSE Office of the Secretary of Defense Missile Defense Advisory Committee Department of Defense; Missile Defense Agency (MDA). ACTION: Notice of Closed Meeting. mstockstill on PROD1PC66 with NOTICES AGENCY: SUMMARY: Under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended) and the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended) and 41 CFR 102–3.150, the Department of Defense announces that the following Federal advisory committee meeting will take place. Name of Committee: Missile Defense Advisory Committee. Dates of Meeting: Wednesday, December 19 and Thursday, December 20, 2007. Time: 8 a.m. to 5 p.m. Security clearance and visit requests are required for access. Location: 7100 Defense Pentagon, Washington, DC 20301–7100. Purpose of the Meeting: At this meeting, the Committee will receive classified briefings by Missile Defense Agency senior staff, Program Managers, senior Department of Defense leaders, representatives from industry and the Services on the appropriate role for the Missile Defense Agency in Cruise Missile Defense. Agenda: Topics tentatively scheduled for discussion include, but are not limited to administrative work; responsibilities for Cruise Missile Defense development; current Missile Defense Agency Cruise Missile Defense capabilities and responsibilities; review of governing directives; and Cruise Missile Defense capabilities development programs for the Services. Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102–3.155 the Missile Defense Agency has determined that the meeting shall be closed to the public. The Director, VerDate Aug<31>2005 16:17 Nov 30, 2007 Jkt 214001 Mr. Al Bready, Designated Federal Officer at mdac@mda.mil, phone/voice mail 703– 695–6438, or mail at 7100 Defense Pentagon, Washington, DC 20301–7100. FOR FURTHER INFORMATION CONTACT: PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 67921 Dated: November 27, 2007. L.M. Bynum, Alternate OSD Federal Register, Liaison Officer, Department of Defense. [FR Doc. E7–23333 Filed 11–30–07; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Department of the Army Availability of Non-Exclusive, Exclusive License or Partially Exclusive Licensing of U.S. Patent Concerning Polymerization of Aromatic Monomers Using Derivatives of Hematin Department of the Army, DoD. Notice. AGENCY: ACTION: SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the availability for licensing of U.S. Patent No. U.S. 7,294,686 entitled ‘‘Polymerization of Aromatic Monomers Using Derivatives of Hematin’’ issued November 13, 2007. This patent has been assigned to the United States Government as represented by the Secretary of the Army. FOR FURTHER INFORMATION CONTACT: Mr. Jeffrey DiTullio at U.S. Army Soldier Systems Center, Kansas Street, Natick, MA 01760, Phone; (508) 233–4184 or Email: Jeffrey.Ditullio@natick.army.mil. SUPPLEMENTARY INFORMATION: Any licenses granted shall comply with 35 U.S.C. 209 and 37 CFR part 404. Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. E7–23368 Filed 11–30–07; 8:45 am] BILLING CODE 3710–08–P DEPARTMENT OF DEFENSE Department of the Army Mandatory Provision of Full Replacement Value Coverage by Department of Defense Personal Property Transportation Service Providers (TSPs)/Contractors Department of the Army, DOD. Notice. AGENCY: ACTION: SUMMARY: This cancels the notice previously published in the Federal Register on December 15, 2006 (71 FR 75509). Pursuant to Chapter 157, § 2636a of Title 10 United States Code enacted by Congress on November 26, 2003, as amended by the Department of Defense Authorizations Act for FY 2007, the Military Surface Deployment and Distribution Command (SDDC), as the E:\FR\FM\03DEN1.SGM 03DEN1

Agencies

[Federal Register Volume 72, Number 231 (Monday, December 3, 2007)]
[Notices]
[Page 67921]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-23368]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability of Non-Exclusive, Exclusive License or Partially 
Exclusive Licensing of U.S. Patent Concerning Polymerization of 
Aromatic Monomers Using Derivatives of Hematin

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent No. U.S. 7,294,686 entitled 
``Polymerization of Aromatic Monomers Using Derivatives of Hematin'' 
issued November 13, 2007. This patent has been assigned to the United 
States Government as represented by the Secretary of the Army.

FOR FURTHER INFORMATION CONTACT: Mr. Jeffrey DiTullio at U.S. Army 
Soldier Systems Center, Kansas Street, Natick, MA 01760, Phone; (508) 
233-4184 or E-mail: Jeffrey.Ditullio@natick.army.mil.

SUPPLEMENTARY INFORMATION: Any licenses granted shall comply with 35 
U.S.C. 209 and 37 CFR part 404.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. E7-23368 Filed 11-30-07; 8:45 am]
BILLING CODE 3710-08-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.